These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 24387789)

  • 21. De novo mutations within metabolism networks of amino acid/protein/energy in Chinese autistic children with intellectual disability.
    Chen WX; Liu B; Zhou L; Xiong X; Fu J; Huang ZF; Tan T; Tang M; Wang J; Tang YP
    Hum Genomics; 2022 Nov; 16(1):52. PubMed ID: 36320054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of autism-related
    Wen Z; Cheng TL; Li GZ; Sun SB; Yu SY; Zhang Y; Du YS; Qiu Z
    Mol Autism; 2017; 8():43. PubMed ID: 28785396
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Hubert L; Cannata Serio M; Villoing-Gaudé L; Boddaert N; Kaminska A; Rio M; Lyonnet S; Munnich A; Poirier K; Simons M; Besmond C
    J Med Genet; 2020 Feb; 57(2):138-144. PubMed ID: 31439720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder.
    Mirzaa GM; Chong JX; Piton A; Popp B; Foss K; Guo H; Harripaul R; Xia K; Scheck J; Aldinger KA; Sajan SA; Tang S; Bonneau D; Beck A; White J; Mahida S; Harris J; Smith-Hicks C; Hoyer J; Zweier C; Reis A; Thiel CT; Jamra RA; Zeid N; Yang A; Farach LS; Walsh L; Payne K; Rohena L; Velinov M; Ziegler A; Schaefer E; Gatinois V; Geneviève D; Simon MEH; Kohler J; Rotenberg J; Wheeler P; Larson A; Ernst ME; Akman CI; Westman R; Blanchet P; Schillaci LA; Vincent-Delorme C; Gripp KW; Mattioli F; Guyader GL; Gerard B; Mathieu-Dramard M; Morin G; Sasanfar R; Ayub M; Vasli N; Yang S; Person R; Monaghan KG; Nickerson DA; van Binsbergen E; Enns GM; Dries AM; Rowe LJ; Tsai ACH; Svihovec S; Friedman J; Agha Z; Qamar R; Rodan LH; Martinez-Agosto J; Ockeloen CW; Vincent M; Sunderland WJ; Bernstein JA; ; Eichler EE; Vincent JB; ; Bamshad MJ
    Genet Med; 2020 Mar; 22(3):538-546. PubMed ID: 31723249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
    Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
    Mol Autism; 2017; 8():14. PubMed ID: 28344757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A de novo variant of CHD8 in a patient with autism spectrum disorder.
    Alotaibi M; Ramzan K
    Discoveries (Craiova); 2020 Mar; 8(1):e107. PubMed ID: 32309624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth.
    An Y; Zhang L; Liu W; Jiang Y; Chen X; Lan X; Li G; Hang Q; Wang J; Gusella JF; Du Y; Shen Y
    Hum Genet; 2020 Apr; 139(4):499-512. PubMed ID: 31980904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exome sequencing identifies de novo splicing variant in XRCC6 in sporadic case of autism.
    Sjaarda CP; Wood S; McNaughton AJM; Taylor S; Hudson ML; Liu X; Guerin A; Ayub M
    J Hum Genet; 2020 Mar; 65(3):287-296. PubMed ID: 31827253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.
    Marco EJ; Aitken AB; Nair VP; da Gente G; Gerdes MR; Bologlu L; Thomas S; Sherr EH
    BMC Med Genomics; 2018 May; 11(1):50. PubMed ID: 29801487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder.
    Bae SM; Hong JY
    Clin Psychopharmacol Neurosci; 2018 May; 16(2):129-135. PubMed ID: 29739125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability.
    Zhu W; Li J; Chen S; Zhang J; Vetrini F; Braxton A; Eng CM; Yang Y; Xia F; Keller KL; Okinaka-Hu L; Lee C; Holder JL; Bi W
    Am J Med Genet A; 2018 Apr; 176(4):973-979. PubMed ID: 29423971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current knowledge on the genetics of autism and propositions for future research.
    Bourgeron T
    C R Biol; 2016; 339(7-8):300-7. PubMed ID: 27289453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations.
    Dou Y; Yang X; Li Z; Wang S; Zhang Z; Ye AY; Yan L; Yang C; Wu Q; Li J; Zhao B; Huang AY; Wei L
    Hum Mutat; 2017 Aug; 38(8):1002-1013. PubMed ID: 28503910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.
    Husson T; Lecoquierre F; Cassinari K; Charbonnier C; Quenez O; Goldenberg A; Guerrot AM; Richard AC; Drouin-Garraud V; Brehin AC; Soleimani M; Taton R; Rotharmel M; Rosier A; Chambon P; Le Meur N; Joly-Helas G; Saugier-Veber P; Boland A; Deleuze JF; Olaso R; Frebourg T; Nicolas G; Guillin O; Campion D
    Transl Psychiatry; 2020 Feb; 10(1):77. PubMed ID: 32094338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic reconstruction of autism biology from massive genetic mutation profiles.
    Luo W; Zhang C; Jiang YH; Brouwer CR
    Sci Adv; 2018 Apr; 4(4):e1701799. PubMed ID: 29651456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder.
    Wang C; Horigane SI; Wakamori M; Ueda S; Kawabata T; Fujii H; Kushima I; Kimura H; Ishizuka K; Nakamura Y; Iwayama Y; Ikeda M; Iwata N; Okada T; Aleksic B; Mori D; Yoshida T; Bito H; Yoshikawa T; Takemoto-Kimura S; Ozaki N
    Transl Psychiatry; 2022 Feb; 12(1):84. PubMed ID: 35220405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.
    Järvelä I; Määttä T; Acharya A; Leppälä J; Jhangiani SN; Arvio M; Siren A; Kankuri-Tammilehto M; Kokkonen H; Palomäki M; Varilo T; Fang M; Hadley TD; Jolly A; Linnankivi T; Paetau R; Saarela A; Kälviäinen R; Olme J; Nouel-Saied LM; Cornejo-Sanchez DM; Llaci L; Lupski JR; Posey JE; Leal SM; Schrauwen I
    Hum Genet; 2021 Jul; 140(7):1011-1029. PubMed ID: 33710394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
    O'Roak BJ; Vives L; Fu W; Egertson JD; Stanaway IB; Phelps IG; Carvill G; Kumar A; Lee C; Ankenman K; Munson J; Hiatt JB; Turner EH; Levy R; O'Day DR; Krumm N; Coe BP; Martin BK; Borenstein E; Nickerson DA; Mefford HC; Doherty D; Akey JM; Bernier R; Eichler EE; Shendure J
    Science; 2012 Dec; 338(6114):1619-22. PubMed ID: 23160955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.
    Toma C; Torrico B; Hervás A; Valdés-Mas R; Tristán-Noguero A; Padillo V; Maristany M; Salgado M; Arenas C; Puente XS; Bayés M; Cormand B
    Mol Psychiatry; 2014 Jul; 19(7):784-90. PubMed ID: 23999528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABA/Glutamate synaptic pathways targeted by integrative genomic and electrophysiological explorations distinguish autism from intellectual disability.
    Bonnet-Brilhault F; Alirol S; Blanc R; Bazaud S; Marouillat S; Thépault RA; Andres CR; Lemonnier É; Barthélémy C; Raynaud M; Toutain A; Gomot M; Laumonnier F
    Mol Psychiatry; 2016 Mar; 21(3):411-8. PubMed ID: 26055424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.